RPE65: Role in the Visual Cycle, Human Retinal Disease, and Gene Therapy

Author： Cai Xue   Conley Shannon   Naash Muna  

Publisher： Informa Healthcare

ISSN： 1381-6810

Source： Ophthalmic Genetics, Vol.30, Iss.2, 2009-06, pp. : 57-62

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

RPGR: Role in the photoreceptor cilium, human retinal disease, and gene therapy

By Hosch Jutta   Lorenz Birgit   Stieger Knut  

Ophthalmic Genetics, Vol. 32, Iss. 1, 2011-03 ,pp. : 1-11

Informa Healthcare

Access to resources Recommend Favorite

Successful RPE65 Gene Replacement and Improved Visual Function in Humans

By Koenekoop Robert  

Ophthalmic Genetics, Vol. 29, Iss. 3, 2008-09 ,pp. : 89-91

Informa Healthcare

Access to resources Recommend Favorite

Expression and promoter activation of the Rpe65 gene in retinal pigment epithelium cell lines

By Boulanger Ana   Redmond T. Michael  

Current Eye Research, Vol. 24, Iss. 5, 2002-05 ,pp. : 368-375

Informa Healthcare

Access to resources Recommend Favorite

Shared Decision-Making, Control Preferences and Psychological Well-Being in Patients with RPE65 Deficiency Awaiting Experimental Gene Therapy

By  

Ophthalmic Research, Vol. 54, Iss. 2, 2015-08 ,pp. : 96-102

Karger

Access to resources Recommend Favorite

Gene Therapy for Retinal Disease: What Lies Ahead

By  

Ophthalmologica, Vol. 234, Iss. 1, 2015-08 ,pp. : 1-5

Karger

Access to resources Recommend Favorite